Literature DB >> 2883010

Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.

R Longoni, L Spina, G Di Chiara.   

Abstract

Low doses of BHT 920, LY 171555 and (+)3PPP, three dopamine agonists selective for D-2 receptors, induced yawning in rats. This effect was reduced by the selective D-1 antagonist SCH 23390 but the antagonism did not exceed a 50% reduction from the control values. In contrast, the selective D-2 antagonist (-)sulpiride completely abolished agonist-induced yawning. A 6 h reserpine pretreatment (5 mg/kg i.p.), which depletes brain dopamine (DA) by about 95%, reduced agonist-induced yawning by an extent similar to SCH 23390; in the reserpinized rats, SCH 23390 completely lost the property of blocking agonist-induced yawning while (-)sulpiride retained it. Two 5HT receptor antagonist, ketanserin and metergoline failed to influence agonist-induced yawning. The reportedly selective D-1 agonist, SKF 38393, failed to induce yawning in normal rats as well as in rats pretreated with reserpine 6 or 16 h earlier. If one excludes that SCH 23390 and the D-2 agonists interact with the same DA-receptors, the data are consistent with the possibility that stimulation of D-1 receptors by endogenous DA plays a permissive-facilitatory role for the behavioural expression of D-2 receptor activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2883010     DOI: 10.1016/0014-2999(87)90162-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.

Authors:  L Spina; R Longoni; A Mulas; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats.

Authors:  S Matsumoto; K Yamada; M Nagashima; M Domae; K Shirakawa; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

3.  Involvement of central beta-adrenoceptors in the regulation of yawning responses.

Authors:  K Yamada; S Matsumoto; M Nagashima; M Kumagai; H Kimura; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

4.  The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Dopaminergic D-1 receptors: essential role in morphine-induced hypermotility.

Authors:  R Longoni; L Spina; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.

Authors:  P Collins; C L Broekkamp; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Observational studies of dopamine D1 and D2 agonists in squirrel monkeys.

Authors:  S Rosenzweig-Lipson; P Hesterberg; J Bergman
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

8.  Effects of adenosine agents on apomorphine-induced yawning in rats.

Authors:  M R Zarrindast; F Fatehi; M Mohagheghi-Badi
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

9.  Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.

Authors:  P Collins; C L Broekkamp; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Behavioral effects of selective and nonselective dopamine agonists on young rats after irreversible antagonism of D1 and/or D2 receptors.

Authors:  S A McDougall; C A Crawford; A J Nonneman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.